Key terms
About ABSI
Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ABSI news
Mar 25
10:10pm ET
Analysts Offer Insights on Healthcare Companies: AbSci (ABSI), HilleVax, Inc (HLVX) and Cabaletta Bio (CABA)
Mar 25
7:40am ET
Analysts Are Bullish on Top Healthcare Stocks: CareCloud (CCLD), AbSci (ABSI)
Mar 22
6:28am ET
Buy Rating Affirmed for AbSci: Promising Pipeline and Strategic Partnerships Signal Growth
Mar 21
3:10pm ET
Analysts Are Bullish on Top Healthcare Stocks: Annovis Bio (ANVS), AbSci (ABSI)
Mar 21
7:33am ET
Absci expects cash to fund operations into 1H27
Mar 21
7:33am ET
Absci reports Q4 EPS (25c), consensus (25c)
Mar 05
4:27pm ET
AbSci’s Strategic Financial Moves and Upcoming Catalysts Warrant a Buy Rating with $9 Price Target
Mar 05
4:18pm ET
Absci cash raise removes key share overhang, says Truist
Feb 28
8:09pm ET
Cathie Wood’s ARK Investment bought 2.99M shares of Absci today
Feb 28
11:45am ET
TD Cowen Keeps Their Buy Rating on AbSci (ABSI)
Feb 28
5:58am ET
Absci 16.7M share Spot Secondary priced at $4.50
Feb 27
4:05pm ET
Absci files to sell $75M in common stock
Feb 27
8:45am ET
Largest borrow rate increases among liquid names
Feb 21
7:36am ET
Absci initiates IND-enabling studies for ABS-101
Jan 10
7:36am ET
Absci appoints Sir Pangalos to its board of directors
Jan 08
10:55am ET
Buy Rating for AbSci’s Stock: Promising ABS-101 Data and Strategic Partnerships Drive Positive Outlook
Jan 08
10:47am ET
Absci price target raised to $7 from $4 at H.C. Wainwright
Jan 08
7:28am ET
Absci to present preclinical data for ABS-101
No recent press releases are available for ABSI
ABSI Financials
Key terms
Ad Feedback
ABSI Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ABSI Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range